Federal Contract

Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

See the original posting, the buyer’s contact details, and thousands more contracts like this one

Free account. Already have one? Log in

Get started

Agency

OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

NAICS Code

541714

Department

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Solicitation Type

Solicitation

Solicitation #

75A50126R00001_RFP_NPIVS_27

PSC Code

AN12

Division

BARDA - ASPR / DAAPPO / BARDA DCMA

Performance State

DC

Posted

Mon, August 17, 2026

Response Deadline

Fri, October 30, 2026

Description

BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-19 of this notice.

Similar open contracts